Cerus to Release First Quarter 2014 Results on May 1, 2014

CONCORD, Calif.--()--Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter results will be released on Thursday, May 1 2014, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

To access the live webcast, please visit the Investor Relations page of the Cerus website at http://www.cerus.com/ir. Alternatively, you may access the live conference call by dialing 866-235-9006 (U.S.) or 631-291-4549 (international).

A replay will be available on the company’s website, or by dialing 855-859-2056 (U.S.) or 404-537-3406 (international) and entering conference ID number 13511524. The replay will be available approximately three hours after the call through May 14, 2014.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for more information.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Contacts

Cerus Corporation
Kevin D. Green, 925-288-6138
Vice President, Finance & CFO

Sharing

Contacts

Cerus Corporation
Kevin D. Green, 925-288-6138
Vice President, Finance & CFO